ABSTRACT
The authors explain the main changes in the Russian model of diagnosis-related groups used for medical care payment from the funds of compulsory health insurance in 2021 compared to 2020. New diagnosis-related groups for payment for treatment of patients with malignancies of lymphoid and hematopoietic tissues, treatment and follow-up of patients with new coronavirus in-fection, rehabilitation after COVID-19 and cancer, surgical treatment of large and giant hernias with mesh implants are described. The authors discuss expanding the list of classification criteria for diagnosis-related groups, updating of approaches to cost weight coefficients for calculation of cost of antineoplastic treatment.Copyright © 2021, Media Sphera Publishing Group. All rights reserved.
ABSTRACT
The authors explain the main changes in the Russian model of diagnosis-related groups used for medical care payment from the funds of compulsory health insurance in 2021 compared to 2020. New diagnosis-related groups for payment for treatment of patients with malignancies of lymphoid and hematopoietic tissues, treatment and follow-up of patients with new coronavirus in-fection, rehabilitation after COVID-19 and cancer, surgical treatment of large and giant hernias with mesh implants are described. The authors discuss expanding the list of classification criteria for diagnosis-related groups, updating of approaches to cost weight coefficients for calculation of cost of antineoplastic treatment. © 2021, Media Sphera Publishing Group. All rights reserved.